LEADER 02472nam0 2200517 i 450 001 BVEE052669 005 20170908093227.0 012 $ame,& 9785 nast uado (3) 1612 (R)$2fei 100 $a20130312d1612 ||||0itac50 ba 101 | $alat 102 $afr 181 1$6z01$ai $bxxxe 182 1$6z01$an 200 1 $aExplanatio in Psalmos. Auctore Roberto Bellarmino ex societate Iesu, S.R.E. Tit. s. Maria in via presbytero cardinalj 205 $aEditio postrema, ab ipso auctore aucta, et recognita. .. 210 $aLugduni$csumptibus Horatii Cardon$d1612$eLugduni$gex typographia Ioannis Hanard, d. Iamet$h1612 215 $a\16!, 1088, \28! p.$cfront. calcogr. 4º 300 $aCon il testo dei Salmi 300 $aSegn.: ā⁴ ē⁴ A-7A⁴ 7B² 300 $aFront. calcogr. inciso da Jacques de Fornazeris. 314 $aincisore$9BVEV049799 500 10$aBibbia. Antico Testamento. Salmi $3SBN0073942$91481975 620 $dLione$3RLZL001494 700 1$aBellarmino$b, Roberto$3RAVV070906$4070$0483296 702 1$aFornazeris$b, Jacques : de$f <1594-1619>$3BVEV049799 712 02$aCardon, Horace$d <1.>$3BVEV022281$4650 712 02$aHanard, Jean$3UBOV135557$4650 790 1$aFournasayre$b, Jacques : de$3BVEV133367$zFornazeris, Jacques : de <1594-1619> 790 0$aIacobus de Fornazeri$3MILV335200$zFornazeris, Jacques : de <1594-1619> 790 1$aTorti$b, Matteo$3BVEV066749$zBellarmino, Roberto 790 1$aHesronita$b, Joannes$3BVEV104987$zBellarmino, Roberto 790 1$aBellarmino$b, Roberto$c $3CFIV143657$zBellarmino, Roberto 790 0$aFranciscus Romulus$3CFIV203156$zBellarmino, Roberto 790 1$aForti$b, Matteo$c $3CFIV203157$zBellarmino, Roberto 790 1$aBellarmino$b, Roberto Francesco Romolo$3CFIV288863$zBellarmino, Roberto 790 1$aRomulus$b, Franciscus$3PUVV217700$zBellarmino, Roberto 790 0$aRoberto : Bellarmino$c $3SBNV027464$zBellarmino, Roberto 791 02$aCardon, Horatius$3CFIV315141$zCardon, Horace <1.> 791 02$aAnard, Jean$3UBOV135558$zHanard, Jean 801 3$aIT$bIT-NA0079$c20130312 850 $aIT-SA0253 912 $aBVEE052669 950 0$aBiblioteca Comunale Gherardo Marone$d 86F. ANTICO Scaff. 15/1. liv. FA 4$e 86 0000000055 B $fZ $h20130312$i20130312 977 $a 86 996 $aBibbia. Antico Testamento. Salmi$91481975 997 $aUNISANNIO LEADER 05430nam 2200685 450 001 9910821059903321 005 20230120002219.0 010 $a0-12-802593-X 010 $a0-12-802443-7 035 $a(CKB)3710000000353069 035 $a(EBL)1948969 035 $a(SSID)ssj0001548711 035 $a(PQKBManifestationID)16153072 035 $a(PQKBTitleCode)TC0001548711 035 $a(PQKBWorkID)14802547 035 $a(PQKB)11532044 035 $a(MiAaPQ)EBC1948969 035 $a(Au-PeEL)EBL1948969 035 $a(CaPaEBR)ebr11019349 035 $a(CaONFJC)MIL732181 035 $a(OCoLC)903442569 035 $a(EXLCZ)993710000000353069 100 $a20150220h20152015 uy 0 101 0 $aeng 135 $aur|n|---||||| 181 $ctxt 182 $cc 183 $acr 200 00$aVitamins and hormones$hVolume ninety-seven$iNociceptin opioid /$fseries editor, Gerald Litwack 205 $aFirst edition. 210 1$aWaltham, Massachusetts :$cAcademic Press,$d2015. 210 4$d2015 215 $a1 online resource (392 p.) 225 1 $aVitamins and Hormones,$x0083-6729 ;$vVolume 97 300 $aDescription based upon print version of record. 311 $a1-336-00899-7 320 $aIncludes bibliographical references at the end of each chapters and index. 327 $aFront Cover; Nociceptin Opioid; Copyright; Contents; Contributors; Preface; Chapter 1: Helix-Constrained Nociceptin Peptides Are Potent Agonists and Antagonists of ORL-1 and Nociception; 1. Nociception in Brief; 1.1. Opioid receptor-like receptor-ORL-1; 1.2. Nociceptin; 1.3. Interrogating the activation and address domains of nociceptin(1-17); 2. Prospecting the Importance of the N-Terminal Tetrapeptide of Nociceptin(1-17); 3. Other Modifications to Nociceptin(1-17); 4. The Importance of Structure in Nociceptin Analogues; 4.1. Importance of helicity; 4.2. Other nociceptin derivatives 327 $a5. Recent Advances in ORL-1 Active Nociceptin Peptides6. The Development of New Helix-Constrained Nociceptin Analogues; 6.1. Design of helix-constrained nociceptin analogues; 6.2. Helical structure of nociceptin(1-17)-NH2 analogues in water; 6.3. Nuclear magnetic resonance spectra-derived structures; 7. Biological Properties of Helical Nociceptin Mimetics; 7.1. Cellular expression of ORL-1 and ERK phosphorylation; 7.2. Agonist and antagonist activity of nociceptin(1-17)-NH2 and analogues; 7.3. Effects of helical constraint on biological activity in Neuro-2a cells 327 $a7.4. Stability and cell toxicity of helix-constrained versus unconstrained peptides7.5. In vivo activity of helix-constrained versus unconstrained nociceptin analogues; 8. Concluding Remarks; References; Chapter 2: Bioinformatics and Evolution of Vertebrate Nociceptin and Opioid Receptors; 1. Introduction; 1.1. The origin of G protein-coupled receptors; 1.2. A brief history of opioid receptors; 1.3. Evidence for opioid receptors in nonmammalian vertebrates; 2. The Vertebrate Opioid Receptor Sequence Database; 2.1. Alignment of protein sequences 327 $a2.2. Phylogenetic analysis of vertebrate opioid receptors2.3. Divergence and convergence of opioid receptor types; 3. The Human Genome and the Evolution of Opioid Receptors; 3.1. Duplicated opioid family receptor genes in the human genome; 3.2. Variation in human opioid receptor genes; 4. The Molecular Evolution of Vertebrate Opioid Family Receptors; 5. Future Directions; 6. Conclusions; Acknowledgments; References; Chapter 3: Ancestral Vertebrate Complexity of the Opioid System; 1. Introduction; 2. Opioid Peptide Family; 3. Opioid Receptor Family 327 $a4. Discussion: Complexity, Coevolution, and Divergence5. Conclusions; Acknowledgement; References; Chapter 4: Synthesis and Biological Activity of Small Peptides as NOP and Opioid Receptors' Ligands: View on Current Devel...; 1. Introduction; 2. Endogenous Opioid Peptides and Receptors: Nociceptin and NOP Receptor Ligands; 3. Hexapeptides with NOP Receptor Affinity; 4. Solid-Phase Peptide Synthesis; 5. Conclusions; Acknowledgment; References; Chapter 5: Pain Regulation by Nocistatin-Targeting Molecules: G Protein-Coupled-Receptor and Nocistatin-Interacting Protein; 1. Introduction 327 $a2. Biological Activity by NST Through G Protein-Coupled Receptor 330 $aFirst published in 1943, Vitamins and Hormones is the longest-running serial published by Academic Press. The Series provides up-to-date information on vitamin and hormone research spanning data from molecular biology to the clinic. A volume can focus on a single molecule or on a disease that is related to vitamins or hormones. A hormone is interpreted broadly so that related substances, such as transmitters, cytokines, growth factors and others can be reviewed. This volume focuses on nociceptin opioid. Key features: Expertise of the contributorsCoverage of a vast array of subjectsIn 410 0$aVitamins and hormones ;$vVolume 97. 606 $aNeuropeptides 606 $aOpioid peptides 606 $aNociceptive pain 615 0$aNeuropeptides. 615 0$aOpioid peptides. 615 0$aNociceptive pain. 676 $a612.015756 702 $aLitwack$b Gerald 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910821059903321 996 $aVitamins and hormones$9762543 997 $aUNINA